This company listing is no longer active
VLNS Stock Overview
The Valens Company Inc., through its subsidiaries, develops, manufactures, and sells cannabinoid-based products in Canada, the United States, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
The Valens Company Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$1.01 |
| 52 Week High | CA$3.79 |
| 52 Week Low | CA$0.76 |
| Beta | 1.79 |
| 1 Month Change | 12.22% |
| 3 Month Change | 9.78% |
| 1 Year Change | -59.44% |
| 3 Year Change | -91.02% |
| 5 Year Change | -86.15% |
| Change since IPO | -32.67% |
Recent News & Updates
Recent updates
These Analysts Just Made A Huge Downgrade To Their The Valens Company Inc. (TSE:VLNS) EPS Forecasts
Mar 05
Some Analysts Just Cut Their The Valens Company Inc. (TSE:VLNS) Estimates
Feb 09Is Valens (TSE:VLNS) Using Debt Sensibly?
Oct 19When Will The Valens Company Inc. (TSE:VLNS) Breakeven?
Mar 24The Valens Company Inc. (TSE:VLNS) Analysts Just Cut Their EPS Forecasts
Jan 22Is Valens (TSE:VLNS) Using Too Much Debt?
Dec 08Shareholder Returns
| VLNS | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | -1.9% | -3.6% | 0.7% |
| 1Y | -59.4% | 54.7% | 5.5% |
Return vs Industry: VLNS matched the Canadian Pharmaceuticals industry which returned -59.9% over the past year.
Return vs Market: VLNS underperformed the Canadian Market which returned -3% over the past year.
Price Volatility
| VLNS volatility | |
|---|---|
| VLNS Average Weekly Movement | 13.4% |
| Pharmaceuticals Industry Average Movement | 13.8% |
| Market Average Movement | 9.1% |
| 10% most volatile stocks in CA Market | 18.2% |
| 10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: VLNS's share price has been volatile over the past 3 months.
Volatility Over Time: VLNS's weekly volatility (13%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 445 | n/a | www.thevalenscompany.com |
The Valens Company Inc., through its subsidiaries, develops, manufactures, and sells cannabinoid-based products in Canada, the United States, and internationally. The company provides packaged dried flower/pre-rolls under the Verse, Versus, Contraband, and Citizen Stash brands; vapourizers and hydrocarbon extracts under the Verse and Versus brands; edible cannabis products under the Verse, Vacay, and LYF brands; and topical cannabis under the Nuance brand. It also offers analytical testing services to third party licensed producers in the cannabis space.
The Valens Company Inc. Fundamentals Summary
| VLNS fundamental statistics | |
|---|---|
| Market cap | CA$81.67m |
| Earnings (TTM) | -CA$235.52m |
| Revenue (TTM) | CA$85.89m |
1.0x
P/S Ratio-0.3x
P/E RatioIs VLNS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VLNS income statement (TTM) | |
|---|---|
| Revenue | CA$85.89m |
| Cost of Revenue | CA$88.93m |
| Gross Profit | -CA$3.03m |
| Other Expenses | CA$232.49m |
| Earnings | -CA$235.52m |
Last Reported Earnings
Aug 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.91 |
| Gross Margin | -3.53% |
| Net Profit Margin | -274.21% |
| Debt/Equity Ratio | 75.7% |
How did VLNS perform over the long term?
See historical performance and comparison